InMode INMD Stock
InMode Price Chart
InMode INMD Financial and Trading Overview
| InMode stock price | 17.92 USD |
| Previous Close | 36.42 USD |
| Open | 36.05 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 1300 |
| Day's Range | 36.01 - 37.02 USD |
| 52 Week Range | 21.71 - 41.84 USD |
| Volume | 890.5K USD |
| Avg. Volume | 1.25M USD |
| Market Cap | 3.07B USD |
| Beta (5Y Monthly) | 2.085008 |
| PE Ratio (TTM) | 17.538097 |
| EPS (TTM) | 2.3 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 47 USD |
INMD Valuation Measures
| Enterprise Value | 2.49B USD |
| Trailing P/E | 17.538097 |
| Forward P/E | 12.317726 |
| PEG Ratio (5 yr expected) | 1.04 |
| Price/Sales (ttm) | 6.461351 |
| Price/Book (mrq) | 5.0793 |
| Enterprise Value/Revenue | 5.252 |
| Enterprise Value/EBITDA | 12.18 |
Trading Information
InMode Stock Price History
| Beta (5Y Monthly) | 2.085008 |
| 52-Week Change | 66.05% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 41.84 USD |
| 52 Week Low | 21.71 USD |
| 50-Day Moving Average | 34.7 USD |
| 200-Day Moving Average | 34.12 USD |
INMD Share Statistics
| Avg. Volume (3 month) | 1.25M USD |
| Avg. Daily Volume (10-Days) | 1.16M USD |
| Shares Outstanding | 83.07M |
| Float | 71.84M |
| Short Ratio | 5.77 |
| % Held by Insiders | 13.63% |
| % Held by Institutions | 59.45% |
| Shares Short | 7.27M |
| Short % of Float | 9.44% |
| Short % of Shares Outstanding | 8.72% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 36.05% |
| Operating Margin (ttm) | 42.96% |
| Gross Margin | 83.77% |
| EBITDA Margin | 43.12% |
Management Effectiveness
| Return on Assets (ttm) | 22.46% |
| Return on Equity (ttm) | 33.99% |
Income Statement
| Revenue (ttm) | 474.42M USD |
| Revenue Per Share (ttm) | 5.75 USD |
| Quarterly Revenue Growth (yoy) | 23.50% |
| Gross Profit (ttm) | 380.79M USD |
| EBITDA | 204.57M USD |
| Net Income Avi to Common (ttm) | 171.05M USD |
| Diluted EPS (ttm) | 2.1 |
| Quarterly Earnings Growth (yoy) | 30.80% |
Balance Sheet
| Total Cash (mrq) | 574.45M USD |
| Total Cash Per Share (mrq) | 6.91 USD |
| Total Debt (mrq) | 3.53M USD |
| Total Debt/Equity (mrq) | 0.59 USD |
| Current Ratio (mrq) | 10.976 |
| Book Value Per Share (mrq) | 7.251 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 170.84M USD |
| Levered Free Cash Flow (ttm) | 136.84M USD |
Profile of InMode
| Country | United States |
| State | N/A |
| City | Yokne'am |
| Address | Tavor Building |
| ZIP | 2069206 |
| Phone | 972 4 909 6313 |
| Website | https://www.inmodemd.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 480 |
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
Q&A For InMode Stock
What is a current INMD stock price?
InMode INMD stock price today per share is 17.92 USD.
How to purchase InMode stock?
You can buy INMD shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for InMode?
The stock symbol or ticker of InMode is INMD.
Which industry does the InMode company belong to?
The InMode industry is Medical Devices.
How many shares does InMode have in circulation?
The max supply of InMode shares is 84.62M.
What is InMode Price to Earnings Ratio (PE Ratio)?
InMode PE Ratio is 7.79130460 now.
What was InMode earnings per share over the trailing 12 months (TTM)?
InMode EPS is 2.3 USD over the trailing 12 months.
Which sector does the InMode company belong to?
The InMode sector is Healthcare.
InMode INMD included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}